Not one person who has any claim to familiarity with India's pharmaceuticals landscape can pretend to be surprised by the findings of a recent report on the functioning of CDSCO - India's equivalent of the US FDA. However, the report performs a very important task which is putting together recent facts and evidence in the … Continue reading India’s drug regulatory regime sucks. What now?
Apothecurry 